Research & Development



  楊沖喜笑顏開,與平頌客氣一番就離開了客房。   雲瑯搖頭道︰“不能用強硬手段!”得得去,得得干   “應該是這樣。”得得去在线   按照春風樓主人的說法,每一座大城里都該有一座這樣的樓閣,否則,富貴者無顯貴之地,貧者無仰望之所。   “雲氏真的有好多蜜糖嗎?”蘭喬對狗子說的事情毫不在意,她更加關心她的蜜糖,自從生產的前一天,狗子給她弄來了一丁點蜜糖之後,這種味道就讓她永生難忘。得得干在线   雲瑯搖頭道︰“你錯了,你是當宰相的最好人選。”

Our discovery and development platforms for drug and cell-based therapies allow us to both create and retain significant value within our therapeutic franchise areas of cancer and inflammatory diseases. Scientists and physicians at Celgene are the driving force behind our success, enabling target-to-therapeutic platforms that integrate both small-molecule and cell-based therapies.

Connect? Registries

The Connect??Registries are observational, hematologic patient registry studies in Multiple Myeloma (Connect?MM), Chronic Lymphocytic Leukemia (Connect?CLL) and Myelodysplastic Syndromes/Acute Myeloid Leukemia (Connect?MDS/AML) and are sponsored by Celgene Corporation. These studies are designed to observe the routine care of patients through the course of their disease. Unlike clinical trials, registries do not require or provide any specific medications or healthcare services, but leave those decisions to the treating doctors and their patients.
Connect? Registries logo